Key facts
- It has raised $4.5M; the latest was Early Stage VC ($4.5M) in Apr 2025.
- Notable investors include Enterprise Ireland, Western Development Commission, Michael Kinsella, Peter Mulrooney.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Galway Biomedical
- ·The full record, as it builds
Funding rounds
No funding rounds for Galway Biomedical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Galway Biomedical
Developer of biomaterial-based implantable medical devices designed to support development and scalable production. The company offers contract development and manufacturing services, including concept design, feasibility testing, rapid prototyping, complex braiding and coating, and cleanroom-based volume manufacturing under certified quality systems, enabling medical device companies to develop regulatory-compliant implant products and scale production efficiently across multiple clinical applications.
- Sector
- Healthcare
- HQ
- Galway, Ireland
- Founded
- 2024
- Employees
- 1
- Website
- galwaybiomedical.com/
- Ownership
- Privately Held (backing)
Galway Biomedical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Galway Biomedical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Galway Biomedical in its N-PORT filings yet. We sweep new filings monthly.